Advertisement

Functional Characterisation of Human Hepatoma Cell Line HepG2 in 3D Culture

  • Christiane Goepfert
  • Wibke Scheurer
  • Susanne Rohn
  • Britta Rathjen
  • Hans Hoffmeister
  • Ralf Pörtner
Conference paper
Part of the ESACT Proceedings book series (ESACT, volume 5)

Abstract

New challenges in drug development and drug testing arise from regulatory requirements. Animal trials have to be replaced by cell culture assays, preferably by test systems with human material. Standard 2D monolayer cultures are often unsatisfactory and therefore tissue-like 3D cultures are suggested as an alternative. In this study in vitro assessment of hepatocyte xenobiotic metabolism was examined. 2D and 3D cultures of hepatoma cells (HepG2) were compared for their xenobiotic metabolising capacity determined by measuring the EROD (Cytochrome P450 1A1 and 1A2) activity. The results indicate that 3D cultivation resulted in altered kinetic characteristics compared to monolayer culture. The measurement of hepatocyte drug and xenobiotic metabolising enzymes in 3D cultures appears to be a promising approach for the testing of chronic toxicity and long term effects of pharmaceuticals in a human hepatic model in vitro.

Keywords

Monolayer Culture Human Hepatocyte Xenobiotic Metabolise Animal Trial Cell Culture Assay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Donato M, Gómez-Lechón M, Castell J (1993) A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 213: 29–33.PubMedCrossRefGoogle Scholar
  2. Fassnacht D, Rössing S, Stange J, Pörtner R (1998) Long-term cultivation of immortalised mouse hepatocytes in a high cell density fixed bed reactor. Biotechnol Tech 12: 25–30.CrossRefGoogle Scholar
  3. Gerlach JC (2006) Bioreactors for extracorporeal liver support. Cell Transplant 15(1): 91–103.CrossRefGoogle Scholar
  4. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99: 15655–15660.PubMedCrossRefGoogle Scholar
  5. Linke K, Schanz J, Hansmann J, Walles T, Brunner H, Mertsching H (2007) Engineered liver-like tissue on a capillarized matrix for applied research. Tissue Eng 13(11): 2699–2707.PubMedCrossRefGoogle Scholar
  6. Perrot S, Dutertre-Catella H, Martin C, Warnet JM, Rat P (2003) A new nondestructive cytometric assay based on resazurin metabolism and an organ culture model for the assessment of corneal viability. Cytometry A 55A: 7–14.CrossRefGoogle Scholar
  7. Pörtner R, Nagel-Heyer St, Goepfert Ch, Adamietz P, Meenen NM (2005) Bioreactor design for tissue engineering. J Biosci Bioeng 100(3): 235–245.PubMedCrossRefGoogle Scholar
  8. Pörtner R, Platas OB, Fassnacht D, Nehring D, Czermak P, Märkl H (2007) Fixed bed reactors for the cultivation of mammalian cells: design, performance and scale-up. Open Biotechnol J 1: 41–46.Google Scholar
  9. Prestwich GD (2008) Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res 41(1): 139–148.PubMedCrossRefGoogle Scholar
  10. Simpson NH, Milner AE, Al-Rubeai M (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng 54(1): 1–16.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Christiane Goepfert
    • 1
  • Wibke Scheurer
    • 1
  • Susanne Rohn
    • 1
  • Britta Rathjen
    • 1
  • Hans Hoffmeister
    • 2
  • Ralf Pörtner
    • 1
  1. 1.Hamburg University of TechnologyHamburgGermany
  2. 2.Zellwerk GmbHOberkraemerGermany

Personalised recommendations